Save on this medicine
Other brands with the same active ingredient
These brands contain the same active ingredient (Artemether + Lumefantrine). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.
ইঙ্গিত ও ব্যবহার
Malfan এর জন্য নির্দেশিত:
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
Adults:
Patients with acute malaria often have little appetite. This medicine should be taken with high fat food or a drink such as milk. If vomiting occurs within 1 hour of taking a dose, the dose should be repeated. Adults and children weighing 35 kg and above: the standard course runs 3 days with a total of 6 doses. Take 4 tablets as a single dose at the time of initial diagnosis, another 4 tablets after eight hours, then 4 tablets twice daily, morning and evening, on each of the following two days. The full course comprises 24 tablets. 5 kg to under 15 kg body weight: take 1 tablet at the time of initial diagnosis, 1 tablet again after 8 hours, then 1 tablet twice daily, morning and evening, on each of the following two days. The full course comprises 6 tablets. 15 kg to under 25 kg body weight: take 2 tablets as a single dose at the time of initial diagnosis, 2 tablets again after 8 hours, then 2 tablets twice daily, morning and evening, on each of the following two days. The full course comprises 12 tablets. 25 kg to under 35 kg body weight: take 3 tablets as a single dose at the time of initial diagnosis, 3 tablets again after 8 hours, then 3 tablets twice daily, morning and evening, on each of the following two days. The full course comprises 18 tablets.
পার্শ্বপ্রতিক্রিয়া
Artemether + Lumefantrine is generally well tolerated by both children and adults, and most side effects that do occur are mild to moderate and don't last long. Reported effects include allergic reactions, headache, dizziness, sleep disturbances, drowsiness, involuntary muscle twitching, tingling or numbness of the skin, an unsteady or abnormal way of walking, loss of coordination, palpitations, cough, abdominal pain, loss of appetite, diarrhoea, vomiting, nausea, itching, rash, joint pain, muscle pain, weakness, and tiredness.
সতর্কতা ও নিষেধাজ্ঞা
Warnings & Precautions
This medicine has not been studied for malaria prevention, so it should not be used for that purpose. It has also not been tested for treating cerebral malaria or other severe forms of malaria, such as those involving fluid in the lungs or kidney failure.
নিষেধাজ্ঞা
Hypersensitivity to any of the ingredients or excipients. Patients with severe malaria as defined by WHO. Use during the first trimester of pregnancy. A family history of congenital QTc interval prolongation or sudden death, or any other condition known to prolong the QTc interval, such as a history of symptomatic cardiac arrhythmias with clinically relevant bradycardia or severe cardiac disease. Known disturbances of electrolyte balance, such as hypokalaemia or hypomagnesemia. Concurrent use of drugs metabolized by the CYP2D6 enzyme, such as flecainide, metoprolol, imipramine, amitriptyline, or clomipramine.